| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA990007839230403321 |
|
|
Autore |
Cotterill, Janet |
|
|
Titolo |
Language and power in court : a linguistic analysis of the O.J. Simpson trial / Janet Cotterill |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
New York : Palgrave Macmillan, 2003 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Locazione |
|
|
|
|
|
|
Collocazione |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
2. |
Record Nr. |
UNINA9910455072803321 |
|
|
Titolo |
Clinical trials handbook [[electronic resource] /] / edited by Shayne Cox Gad |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Hoboken, NJ, : Wiley, c2009 |
|
|
|
|
|
|
|
ISBN |
|
1-282-36844-3 |
9786612368448 |
0-470-46636-7 |
0-470-46635-9 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (1247 p.) |
|
|
|
|
|
|
Collana |
|
Pharmaceutical Development Series ; ; v.8 |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
Drugs - Testing |
Clinical trials |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Clinical Trials Handbook; Contents; Preface; Contributors; 1 Introduction to Clinical Trials; 2 Regulatory Requirements for Investigational New Drug; 3 Preclinical Assessment of Safety in Human Subjects; 4 Predicting Human Adverse Drug Reactions from Nonclinical Safety Studies; 5.1 History of Clinical Trial Development and the Pharmaceutical Industry; 5.2 Adaptive Research; 6 Organization and Planning; 7 Process of Data Management; 8 Clinical Trials Data Management; 9.1 Clinical Trials and the Food and Drug Administration; 9.2 Phase I Clinical Trials; 9.3 Phase II Clinical Trials |
9.4 Designing and Conducting Phase III Studies9.5 Phase IV: Postmarketing Trials; 9.6 Phase IV and Postmarketing Clinical Trials; 9.7 Regulatory Approval; 9.8 New Paradigm for Analyzing Adverse Drug Events; 10.1 Clinical Trials in Interventional Cardiology: Focus on XIENCE Drug-Eluting Stent; 10.2 Clinical Trials Involving Oral Diseases; 10.3 Dermatology Clinical Trials; 10.4 Emergency Clinical Trials; 10.5 Gastroenterology; 10.6 Gynecology Randomized Control Trials; 10.7 Special Population Studies (Healthy Patient Studies); 10.8 Musculoskeletal Disorders; 10.9 Oncology |
10.10 Pharmacological Treatment Options for Nonexudative and Exudative Age-Related Macular Degeneration10.11 Paediatrics; 10.12 Clinical Trials in Dementia; 10.13 Clinical Trials in Urology; 10.14 Clinical Trials on Cognitive Drugs; 10.15 Bridging Studies in Pharmaceutical Safety Assessment; 10.16 Brief History of Clinical Trials on Viral Vaccines; 11 Methods of Randomization; 12 Randomized Controlled Trials; 13 Cross-Over Designs; 14.1 Biomarkers; 14.2 Biomarkers in Clinical Drug Development: Parallel Analysis of Alzheimer Disease and Multiple Sclerosis; 15 Review Boards |
16 Size of Clinical Trials17 Blinding and Placebo; 18 Pharmacology; 19 Modeling and Simulation in Clinical Drug Development; 20 Monitoring; 21 Inference Following Sequential Clinical Trials; 22 Statistical Methods for Analysis of Clinical Trials; 23 Explanatory and Pragmatic Clinical Trials; 24.1 Ethics of Clinical Research in Durg Trials; 24.2 Ethical Issues in Clinical Research; 25 Regulations; 26 Future Challenges in Design and Ethics of Clinical Trials; 27 Proof-of-Principle/Proof-of-Concept Trials in Drug Development; Index |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Best practices for conducting effective and safe clinical trials Clinical trials are arguably the most important steps in proving drug effectiveness and safety for public use. They require intensive planning and organization and involve a wide range of disciplines: data management, biostatistics, pharmacology, toxicology, modeling and simulation, regulatory monitoring, ethics, and particular issues for given disease areas. Clinical Trials Handbook provides a comprehensive and thorough reference on the basics and practices of clinical trials. With contributions from a range of |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3. |
Record Nr. |
UNINA9910781214503321 |
|
|
Autore |
Dale John G |
|
|
Titolo |
Free Burma [[electronic resource] ] : transnational legal action and corporate accountability / / John G. Dale |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Minneapolis, : University of Minnesota Press, c2011 |
|
|
|
|
|
|
|
ISBN |
|
1-4529-4589-6 |
0-8166-7653-4 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (328 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
United States Foreign relations Law and legislation |
Burma International status |
Burma Politics and government 1988- |
United States Foreign relations Burma |
Burma Foreign relations United States |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Burma's struggle for democracy and human rights before 1988 -- Locating power in the free Burma movement -- Free Burma laws : legislating transnational sanctions -- Corporate "death penalty" : executing charter revocation -- Alien tort claims : adjudicating human rights abuses abroad. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
When the military's ruling party violently quashed Burma's pro-democracy movement, diplomatic condemnation quickly followed--to little effect. But when Burma's activists began linking the movement to others around the world, the result was dramatically different. This book is the first to explain how Burma's pro-democracy movement became a transnational social movement for human rights. Through the experience of the Free Burma movement, John G. Dale demonstrates how social movements create and appropriate legal mechanisms for generating new transnational political opportunities. He presents th |
|
|
|
|
|
|
|
| |